---
title: "Valrubicin - Urinary Bladder Neoplasms"
sidebar: mydoc_sidebar
permalink: db00385-mesh-d001749-1.html
toc: false 
---


Path ID: `DB00385_MESH_D001749_1`
{% include image.html url="images/db00385-mesh-d001749-1.png" file="db00385-mesh-d001749-1.png" alt="db00385-mesh-d001749-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C016163">MESH:C016163 </a> | valrubicin | Drug |
| <a href="https://identifiers.org/UniProt:P11388">UniProt:P11388 </a> | DNA topoisomerase 2-alpha | Protein |
| <a href="https://identifiers.org/GO:0006260">GO:0006260 </a> | DNA replication | BiologicalProcess |
| <a href="https://identifiers.org/CL:0001063">CL:0001063 </a> | neoplastic cell | Cell |
| <a href="https://identifiers.org/MESH:D001749">MESH:D001749 </a> | Urinary Bladder Neoplasms | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Valrubicin | DECREASES ACTIVITY OF | Dna Topoisomerase 2-Alpha |
| Dna Topoisomerase 2-Alpha | POSITIVELY REGULATES | Dna Replication |
| Dna Replication | OCCURS IN | Neoplastic Cell |
| Neoplastic Cell | POSITIVELY CORRELATED WITH | Urinary Bladder Neoplasms |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00385#mechanism-of-action](https://go.drugbank.com/drugs/DB00385#mechanism-of-action)
  - [https://www.uniprot.org/uniprot/P11388#function](https://www.uniprot.org/uniprot/P11388#function)
  - [https://en.wikipedia.org/wiki/Type_II_topoisomerase](https://en.wikipedia.org/wiki/Type_II_topoisomerase)
  - [https://en.wikipedia.org/wiki/Bladder_cancer](https://en.wikipedia.org/wiki/Bladder_cancer)
